Channelopathy: Difference between revisions

Jump to navigation Jump to search
 
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{SI}}
{{SI}}
{{EH}}
{{CMG}}


==Overview==
'''Channelopathies''' are diseases caused by disturbed function of [[ion channel]] subunits or the [[proteins]] that regulate them.  These diseases may be either [[congenital]] (often resulting from a [[mutation]] or mutations in the encoding genes) or acquired (often resulting from [[autoimmune]] attack on an [[ion channel]]).
'''Channelopathies''' are diseases caused by disturbed function of [[ion channel]] subunits or the [[proteins]] that regulate them.  These diseases may be either [[congenital]] (often resulting from a [[mutation]] or mutations in the encoding genes) or acquired (often resulting from [[autoimmune]] attack on an [[ion channel]]).


Line 55: Line 56:
*Newsom-Davis J, 1997. Autoantibody-mediated channelopathies at the neuromuscular junction Neuroscientist '''3'''(5):337-346.
*Newsom-Davis J, 1997. Autoantibody-mediated channelopathies at the neuromuscular junction Neuroscientist '''3'''(5):337-346.


{{SIB}}
 


[[Category:Channelopathy|*]]
[[Category:Channelopathy|*]]

Latest revision as of 22:47, 3 September 2012

WikiDoc Resources for Channelopathy

Articles

Most recent articles on Channelopathy

Most cited articles on Channelopathy

Review articles on Channelopathy

Articles on Channelopathy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Channelopathy

Images of Channelopathy

Photos of Channelopathy

Podcasts & MP3s on Channelopathy

Videos on Channelopathy

Evidence Based Medicine

Cochrane Collaboration on Channelopathy

Bandolier on Channelopathy

TRIP on Channelopathy

Clinical Trials

Ongoing Trials on Channelopathy at Clinical Trials.gov

Trial results on Channelopathy

Clinical Trials on Channelopathy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Channelopathy

NICE Guidance on Channelopathy

NHS PRODIGY Guidance

FDA on Channelopathy

CDC on Channelopathy

Books

Books on Channelopathy

News

Channelopathy in the news

Be alerted to news on Channelopathy

News trends on Channelopathy

Commentary

Blogs on Channelopathy

Definitions

Definitions of Channelopathy

Patient Resources / Community

Patient resources on Channelopathy

Discussion groups on Channelopathy

Patient Handouts on Channelopathy

Directions to Hospitals Treating Channelopathy

Risk calculators and risk factors for Channelopathy

Healthcare Provider Resources

Symptoms of Channelopathy

Causes & Risk Factors for Channelopathy

Diagnostic studies for Channelopathy

Treatment of Channelopathy

Continuing Medical Education (CME)

CME Programs on Channelopathy

International

Channelopathy en Espanol

Channelopathy en Francais

Business

Channelopathy in the Marketplace

Patents on Channelopathy

Experimental / Informatics

List of terms related to Channelopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Channelopathies are diseases caused by disturbed function of ion channel subunits or the proteins that regulate them. These diseases may be either congenital (often resulting from a mutation or mutations in the encoding genes) or acquired (often resulting from autoimmune attack on an ion channel).

There are a large number of distinct dysfunctions known to be caused by ion channel mutations. The genes for the construction of ion channels are highly conserved amongst mammals and one condition, hyperkalemic periodic paralysis, was first identified in the descendants of Impressive, a pedigree race horse.

The channelopathies of human skeletal muscle include hyper-, hypo- and normokalemic (high, low and normal potassium blood concentrations) periodic paralysis, myotonia congenita and paramyotonia congenita.

Types

References

  • Robert S. Kass (2005). "The channelopathies: novel insights into molecular and genetic mechanisms of human disease". Journal of Clinical Investigation. 115 (8): 1986&ndash, 1989. PMID 16075038.

Further reading

  • Ashcroft F.M., Ion Channels and Disease. 2000. Academic Press.
  • Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, Morris C & NewsomDavis J. 1997. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Annals OF Neurology 41(2):238-246 .
  • Lehmann-Horn,F. & Jurkatt-Rott,K. 1999. Voltage-Gated Ion Channels and Hereditary Disease. PHYSIOLOGICAL REVIEWS 79(4).
  • Newsom-Davis J, 1997. Autoantibody-mediated channelopathies at the neuromuscular junction Neuroscientist 3(5):337-346.


Template:WS